1. Home
  2. CAPT vs OSRH Comparison

CAPT vs OSRH Comparison

Compare CAPT & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAPT

Captivision Inc.

HOLD

Current Price

$0.39

Market Cap

13.2M

Sector

Finance

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.68

Market Cap

15.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPT
OSRH
Founded
2005
N/A
Country
South Korea
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
15.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CAPT
OSRH
Price
$0.39
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
423.0K
Earning Date
01-01-0001
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,389,944.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
84.70
N/A
52 Week Low
$0.30
$0.45
52 Week High
$1.94
$12.54

Technical Indicators

Market Signals
Indicator
CAPT
OSRH
Relative Strength Index (RSI) 41.81 56.83
Support Level $0.36 $0.55
Resistance Level $0.58 $0.65
Average True Range (ATR) 0.07 0.06
MACD 0.02 0.01
Stochastic Oscillator 33.94 83.59

Price Performance

Historical Comparison
CAPT
OSRH

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: